Skip to Content
Merck

Skip To

Z370665

Sigma-Aldrich

Biohazard waste container

capacity 19 L (5 gal)

Synonym(s):

autoclave waste disposal, biohaz waste bag, biohazardous disposal bags, waste bags

Sign Into View Organizational & Contract Pricing

Select a Size

Change View
10 G
₹5,060.00
50 G
₹16,346.00
250 G
₹54,901.00

About This Item

UNSPSC Code:
41123300
NACRES:
NB.35

₹5,060.00


Please contact Customer Service for Availability

Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

packaging

pack of 1 ea

manufacturer/tradename

Nalgene 6370-0005

O.D. × H

28 cm (11 in.) × 43 cm (17 in.)

capacity

19 L (5 gal)

Looking for similar products? Visit Product Comparison Guide

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
TMO6370-0004Z370673HS1002C
manufacturer/tradename

Nalgene 6370-0005

manufacturer/tradename

Nalge-Nunc 6370-0004

manufacturer/tradename

Nalgene 6370-0015

manufacturer/tradename

Heathrow Scientific HS1002C

capacity

19 L (5 gal)

capacity

-

capacity

57 L (15 gal)

capacity

-

packaging

pack of 1 ea

packaging

pack of 1 ea

packaging

pack of 1 ea

packaging

-

O.D. × H

28 cm (11 in.) × 43 cm (17 in.)

O.D. × H

-

O.D. × H

34 cm (13.25 in.) × 74 cm (29 in.)

O.D. × H

-

General description

Biohazardous Waste Containers are ideal autoclavable polypropylene containers for secondary containment of biohazardous waste materials.

Convenient one-step sterilization; no need to remove bag. Port opening in cover allows one-handed disposal of materials; limits exposure to infectious waste. Holds standard sized autoclave bags. Will not rust, dent or puncture.

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Reversed phase HPLC method for determination of glimepiride in tablet dosage form
Wanjari DB and Gaikwad NJ
Indian Journal of Pharmaceutical Sciences, 67(2), 253-253 (2005)
Glimepiride
USP42/NF37: United States Pharmacopeia and National Formulary
United States Pharmacopeia/National Formulary, 42(6)(6), 2062-2062 (2018)
Simultaneous estimation of metformin hydrochloride, pioglitazone hydrochloride, and glimepiride by RP-HPLC in tablet formulation.
Jain D, et al.
Journal of Chromatographic Science, 46(6), 501-504 (2008)
R K Campbell
The Annals of pharmacotherapy, 32(10), 1044-1052 (1998-10-30)
To review the clinical pharmacology data regarding the sulfonylurea glimepiride, and to summarize the clinical trials of glimepiride efficacy and safety alone and in combination with insulin for the treatment of type 2 diabetes mellitus. A MEDLINE database search (English

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service